Research Studies

PERIPHERAL NEUROPATHY RESEARCHERS INVITED TO PRE-APPLY FOR RESEARCH GRANTS FROM DoD PEER REVIEWED MEDICAL RESEARCH PROGRAM

Leave a Comment / Advocacy, News, Research, Research Studies, webinar / By Jennifer Riskind

The Foundation for Peripheral Neuropathy and the Department of Defense Peer-Reviewed Medical Research Program Co-Host March 8 Webinar About Award Pre-Applications CHICAGO, Feb. 28, 2023 /PRNewswire/ — For the third consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense Peer Reviewed Medical Research Program (PDMRP)’s $370 million fund. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) and the …

PERIPHERAL NEUROPATHY RESEARCHERS INVITED TO PRE-APPLY FOR RESEARCH GRANTS FROM DoD PEER REVIEWED MEDICAL RESEARCH PROGRAM Read More »

PNRR Study on Vitamin B6

Leave a Comment / Idiopathic Neuropathy, News, Research, Research Studies / By Lindsay Colbert

Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels …

PNRR Study on Vitamin B6 Read More »

Research Study Back on Track!

Leave a Comment / Anti-MAG Peripheral Neuropathy, News, Research, Research Studies / By [email protected]

Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to …

Research Study Back on Track! Read More »

michigan medicine university of michigan

FPN Welcomes the University of Michigan and Dr. Amro Stino

Leave a Comment / News, Research, Research Studies, Stories / By Lindsay Colbert

The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome the University of Michigan as a new site for patient enrollments into the Peripheral Neuropathy Research Registry. In this article, FPN’s Executive Director interviews the newest researcher to join this special team, Dr. Amro Stino, and why this new partnership will be fruitful for the …

FPN Welcomes the University of Michigan and Dr. Amro Stino Read More »

Translational Pain Research Study

Leave a Comment / Clinical Trials, News, PN treatments, Research, Research Studies / By Lindsay Colbert

Do you have numbness and tingling or pain in your feet from diabetes? Do you have pain after shingles (postherpetic pain)? The Translational Pain Research Group at the Brigham and Women’s Hospital in Boston, Massachusetts, is seeking volunteers who have diabetic nerve pain or pain following shingles to participate in a research study. Volunteers who …

Translational Pain Research Study Read More »

Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain

Leave a Comment / Clinical Trials, Diabetic Peripheral Neuropathy, News, Research Studies / By Lindsay Colbert

Erchonia Corporation is currently recruiting for a study on the effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy pain. This study can be found at ClinicalTrials.gov here. PURPOSE OF THE STUDY In this study, the Sponsor, Erchonia Corporation, and investigators are studying the use of a device called the Erchonia® FX-635™ that gives …

Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain Read More »

Key Data from FPN Patient Registry Highlighted in Top Medical Journal

Leave a Comment / Idiopathic Neuropathy, News, Research, Research Studies / By Lindsay Colbert

In January 2019, a study was published by the Journal of the Peripheral Nervous System on the design and characteristics of patient data collected from the Peripheral Neuropathy Research Registry (PNRR). This is the first ever overall study performed on this Patient Registry and one that truly highlights the importance of this dataset for current …

Key Data from FPN Patient Registry Highlighted in Top Medical Journal Read More »

Gene Therapy Blocks Peripheral Nerve Damage in Mice

Leave a Comment / News, Research, Research Studies / By Nancy Frohman

In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders, including peripheral neuropathy. The findings of this report, originally reported by Julia Evangelou Strait, can be found below. Nerve axons serve as the …

Gene Therapy Blocks Peripheral Nerve Damage in Mice Read More »

IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S.

3 Comments / Anti-MAG Peripheral Neuropathy, Clinical Trials, News, Research, Research Studies / By Nancy Frohman

The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGiNe study, a global research collaborative focusing on anti-MAG and IgM paraprotein-associated peripheral neuropathy. Thanks to a donation from the Atlantic Philanthropies Director/Employee Designated Gift Fund, FPN …

IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S. Read More »

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy

Leave a Comment / Clinical Trials, News, Research, Research Studies / By Lindsay Colbert

NeuroNEXT and the National Institute of Neurological Disorders and Stroke (NINDS) are undergoing a double-blind, placebo clinical trial looking at the effectiveness of treating peripheral neuropathy with the FDA-approved drug, topiramate. This is a 96-week placebo-controlled trial of topiramate at a target dose of 100 mg daily (50 mg twice daily) as a potentially disease …

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy Read More »